CNTB Connect Biopharma Hldgs1.85-0.08 (-4.2%)
CNTB Connect Biopharma Hldgs2.28-0.48 (-17.4%)
CNTB Connect Biopharma Hldgs1.99-0.10 (-4.8%)
CNTB Connect Biopharma Hldgs1.410.00 (0.0%)
Premarket Decliner
CNTB Connect Biopharma Hldgs5.70-0.22-3.7%
Premarket:5.07-0.63 (-11.1%)
Connect Biopharma Reports Detailed Positive Dataset from the Global Phase 2b Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis
Globe NewswireWed, 5-Jan 7:00 AM
Premarket Gainer
Premarket:6.45+0.75 (+13.2%)